Singlife Shield & Rider Changes (April 2026): Should You Switch to the New Rider?

• Benefit revision

For the main plan, Singlife Shield 2 will see its annual policy limit increased from $1 million to $1.2 million making it the highest in the market. In addition, coverage for Cell, Tissue and Gene Therapy (CTGTP) will be revised to align with MOH guidelines, with benefits now limited to the two approved therapies (Kymriah and Yescarta) under stricter CTGTP rules for both inpatient and outpatient treatment.

For riders, a new Recovery Support Benefit will be introduced and made available to both existing and new Singlife Health Plus riders. This benefit provides up to $20,000 in coverage over two years per lifetime for home nursing and rehabilitation services and is available to policyholders who qualify for the Severe Disability Benefit. Note that this benefit is only available for individuals who have both a Singlife Health Plus rider and a Singlife CareShield or ElderShield plan.

• Premium revision

Premiums for Singlife Shield plans and Singlife Health Plus riders have been revised with changes applicable to policies purchased and renewed after 1 April 2026. Notably, there will be a steep increase (up to 129%) for Health Plus Private Prime and Public Prime riders as these are the old riders that waives annual deductible.

Revised premiums for Singlife Shield Plan:

Note: As Singlife presents premiums on a yearly basis, values are shown at 5-year intervals for ease of comparison. Premiums shown are retrieved on 10 April 2026 for policies issued on standard terms. For illustration purposes only.

Revised premiums for Singlife Health Plus riders:

Note: As Singlife presents premiums on a yearly basis, values are shown at 5-year intervals for ease of comparison. Premiums shown are retrieved on 10 April 2026 for policies issued on standard terms and considers the no claim discount given. For illustration purposes only.

Commonly asked questions about Singlife Shield and its riders
1.      I have a Singlife Health Plus (Private Prime / Private Lite / Public Prime / Public Lite). What happens to my existing rider?

If you purchased your Singlife Health Plus Rider (Private Prime, Private Lite, Public Prime, Public Lite) before 27 November 2025, there are no changes to your rider for now.

If you purchased Singlife Health Plus Rider between 27 November 2025 and 31 March 2026, you must transition to the new Singlife Health Plus Private or Public Rider at your first renewal after 1 April 2028.

2.      How does the new Singlife Health Plus rider compare to the older Prime or Lite riders?

The new Singlife Health Plus riders are simplified to a single rider option unlike the old riders that offered both Prime and Lite rider options.

Here are the other changes between the new and old Singlife Health Plus riders:

• No Deductible Coverage: The new Singlife Health Plus Private and Public riders will no longer cover the annual deductible under your Singlife Shield plan. This means you must pay the deductible first, before any co-insurance or co-payment applies. For existing Lite riders, this is not new with Lite riders already required to pay the deductible before co-payment applied. However, this will be a new requirement for those switching from the Private Prime or Public Prime riders to the new Health Plus Private or Public riders.
• Increased Co-payment Cap: While the new Singlife Health Plus rider still replaces your Shield plan’s co-insurance with a 5% co-payment, the co-payment cap has increased from $3,000 to $6,000. As with the previous riders, this cap applies only to treatments from preferred providers or at A&E. Co-payments for non-preferred providers remain uncapped under the new rider.
• New Recovery Support Benefit: A new Recovery Support Benefit will be introduced to help with long-term recovery, offering up to $20,000 per lifetime (claimable for up to 2 years or 730 consecutive days) for home nursing care and rehabilitation services like physiotherapy and speech therapy. This will apply to both the new and old Singlife Health Plus riders purchased or renewed after 1 April 2026. Note that this benefit is only available for individuals who have both a Singlife Health Plus rider and a Singlife CareShield or ElderShield plan.
• New limits for Cancer Drug Treatments: For Singlife Health Plus Private, CDL treatments for outpatient cancer drug treatment will now be capped at a flat $10,000 per month (revised from the previous limit of 15 times the MediShield Life benefit). Similarly, the cap for non-CDL treatments has been reduced from $15,000 to $10,000 per month.
• Removal of benefit: The new riders will remove coverage for the ward downgrade benefit.
• Premiums: Policyholders can expect larger premium savings when switching from the old Private Prime or Public Prime riders to the new Private rider. In contrast, premium savings are smaller when switching from the old Private Lite or Public Lite riders to the new Lite rider.

A comparison of premium between the new and old riders:

Note: As Singlife presents premiums on a yearly basis, values are shown at 5-year intervals for ease of comparison. Premiums shown are retrieved on 10 April 2026 for policies issued on standard terms and rider considers the no claim discount given. For illustration purposes only.

3.      Should I switch to the new Singlife Health Plus rider?

Policyholders on existing Lite riders have little incentive to switch as the modest premium savings may not justify the reduction in benefits. While the old Lite riders already required payment of the annual deductible, the new riders increase the co-payment cap to $6,000. With premium savings averaging around 10% for those switching to the new Singlife Health Plus rider, this may not be sufficient to offset the additional $3,000 in potential out-of-pocket costs.

Conversely, while Prime rider holders may consider downgrading to manage rising premiums, they should carefully weigh the trade-offs. The new riders come with a higher co-payment cap and no longer cover the annual deductible, resulting in a maximum out-of-pocket expense of up to $9,500, compared to $3,000 under the old riders when using panel providers.

Our recommendation: Keep your existing Prime or Lite riders for now.

4.      What else can be done to enhance my cancer coverage?

Information shown in the table above are for shield plans for treatment at a private hospital. Retrieved on 10 April 2026 and are for illustration purposes only.

While the Singlife Shield plan and Health Plus rider cover your hospital bills and provide cancer coverage, there are limits when it comes to cancer treatments.

For example, if you have Singlife Shield Plan 1 with the Singlife Health Plus Private rider, your outpatient cancer drug treatment is capped at $10,000 per month for CDL treatments, and $10,000 per lifetime for non-CDL treatments. If this is a concern, you may consider enhancing your coverage with a supplementary plan such as Singlife Cancer Cover Plus II. Do note that this is not a MediSave-approved plan.

As shown in the image above, Singlife Cancer Cover Plus II can complement your shield plan and addresses the gaps in cancer treatment costs. While your Shield plan is limited to MOH-approved CDL treatments and capped payouts, this supplementary plan increases your coverage limits, helps pay for eligible expenses that exceed your Shield and rider limits, and extends support to selected non-CDL drugs to reduce out-of-pocket costs. With a high annual limit of up to $1.5 million and coverage for both local and overseas treatments, it provides a stronger financial buffer and greater flexibility in managing cancer care.

5.      With the enhancement to Singlife Shield Plan 2, should I downgrade my Plan 1 now?

Here is a breakdown of the main differences between the Singlife Shield Plan 1 and Plan 2:

• Annual policy limit and ward entitlement: The main differences between the two plans are the annual policy limit and ward entitlement. Singlife Shield Plan 1 offers an annual limit of $2 million for preferred providers and A&E treatments, along with private hospital ward entitlement. Plan 2, on the other hand, has an annual limit of $1.2 million and covers Class A wards at public hospitals. However, for Plan 1, treatments from non-preferred providers are capped at $1 million annually, which is even lower than the $1.2 million annual limit for Plan 2.
• Living donor organ transplant: Singlife Shield Plan 1 provides a lifetime benefit of $50,000, compared to $30,000 under Plan 2. This benefit applies when the insured is the donor. If the insured is the recipient, the transplant is instead covered under the major organ transplant benefit.
• Extra inpatient benefit for 5 critical illnesses: Singlife Shield Plan 1 offers a benefit of up to $150,000 per policy year, as compared to Plan 2’s $100,000 per policy year.
• Inpatient psychiatric treatment: After 10 months of continuous cover, Plan 1 provides as-charged coverage for up to 60 days of inpatient psychiatric treatment per policy year, compared to 45 days under Plan 2. Within the first 10 months, both plans offer the same benefit of $500 per day, capped at 35 days per policy year.
• Premium savings: Singlife Shield Plan 2 is significantly cheaper than Singlife Shield Plan 1 across all age bands, which will help you manage long-term affordability as premiums naturally increase with age.

Whether you should switch from Singlife Shield Plan 1 to Plan 2 depends on your willingness to give up private hospital coverage in exchange for significant long-term premium savings. Plan 2 offers much lower premiums and can help you better manage costs as they increase with age. With the recently increased annual limit of $1.2 million, it is an attractive option for those who are comfortable receiving treatment at public hospitals.

However, if you prefer treatment at private hospitals, it is advisable to remain on Plan 1. Under Plan 2, claims for private healthcare are subject to a 50% pro-ration factor, meaning only half of your bill (before deductibles and co-insurance) is recognised, resulting in significantly higher out-of-pocket expenses.

Our recommendation: Keep Plan 1 if you prefer private hospital treatments or switch to Plan 2 if you are comfortable with getting treated at public hospitals.

Confused by the April 2026 IP Rider Changes? We’ll Help You Review & Save

The 2026 IP rider changes have significantly altered co-payments and premiums. Unsure what to do with your shield plan or rider? Reach out to us for a complimentary review and be rewarded with $50 Cash Reward* plus up to 45% commission rebates if you purchase an eligible shield plan or IP rider.

Don’t have an agent? No problem. Transfer your Income or Raffles plan to us and receive a $5 reward*. As your dedicated agent, we’ll support your Shield policy by assisting with claims and queries, while keeping you updated on any policy changes to ensure your coverage continues to meet your needs.

👉🏻 Click here to get started.

*Terms and conditions can be found here.

Unsure about what to do with your Singlife Shield plan?

Click here to schedule a complimentary review >

You may also be interested in:

• A 2026 Update to your Raffles Shield plan and the new Raffles Choice Rider
• Shield Plan and IP rider changes: This is your 2026 update
• New IP Riders 2026: Should I switch to the new Enhanced IncomeShield riders?
• Your 2026 Guide to Critical Illness Coverage: Pay Less, Get More
• Why is Term Life Insurance Cheaper in Singapore? (A Regional Comparison)

Information obtained from:

https://singlife.com/en/medical-insurance/shield

https://singlife.com/en/medical-insurance/singlife-cancer-cover-plus-ii

Information retrieved on 10 April 2026.

Disclaimer:

All materials and content found in this advertisement are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This advertisement is not a contract of insurance.

Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.

You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.

While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.

The comparisons and opinions provided are based on publicly available data/information and are intended to provide a general overview of the insurance products discussed. These comparisons do not cover all available products and may not fully illustrate every aspect of the products discussed.

Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.

This advertisement has not been reviewed by the Monetary Authority of Singapore.